Glaxosmithkline | GSK - 营业费用



金融业
股票价格
GBP
资产
GBP 62.87B
现金及等价物
GBP 3.44B
销售成本
GBP 1.88B
流动资产
GBP 17.76B
流动负债
GBP 22.43B
债务
GBP 19.06B
股息收益率
GBP 4.47
EBIT
GBP 2.31B
EBITDA
GBP 2.77B
员工
GBP 69.4K
EPS每股收益
GBP 0.62
股本和储备
GBP 17.42B
销售毛利
GBP 5.75B
债务利息支出
GBP 192.73M
利息收入
GBP 22M
贷款资金
GBP 18.53B
市值
GBP 102.54B
净收入
GBP 1.74B
营业费用
GBP 5.34B
营业利润
GBP 2.29B
普通股股本
GBP 4.05B
PE价格收益
15.09
税前利润
GBP 2.14B
销售收入
GBP 10.09B
销售和管理费用
GBP 2.12B
股票
GBP 6.16B
贸易债权人
GBP 14.34B
应收帐款人
GBP 10.49B


营业费用 更改 日
AbbVie USD 10.27B 1000K 2026-06
Amgen USD 11.69B 6.9B 2026-06
AstraZeneca USD 12.22B 4.04B 2026-06
Aurora Cannabis CAD 48.04M 81.94M 2026-03
Bausch Health Companies USD 2.08B 41M 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Canopy Growth CAD 98.72M 11.51M 2026-03
Corcept Therapeutics USD 214.85M 343K 2026-06
Drreddys Laboratories INR 74.33B 1.4B 2026-03
Eli Lilly USD 10.52B 496M 2026-06
GlaxoSmithKline GBP 5.8B 468M 2026-06
Glaxosmithkline GBP 5.34B 3.83B 2026-03
J&J USD 17.83B 388M 2026-06
Merck USD 15.77B 2.4B 2026-06
Novartis USD 10.2B 912M 2026-06
Pacira USD 180.54M 7.79M 2026-06
Perrigo USD 290.5M 645.1M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Phibro Animal Health USD 361.83M 29.47M 2026-03
Prestige Brands USD 213.19M 7.06M 2026-06
Roche Holding CHF 18.9B 2.12B 2026-06
Sanofi EUR 9.92B 607M 2026-06
Supernus Pharmaceuticals USD 1.03B 45.58M 2026-06
Takeda JPY 1.02T 89.68B 2026-06
Teva Pharmaceutical Industries USD 3.92B 691M 2026-06
Zoetis USD 3.15B 85M 2026-06